Bliss GVS Pharma has informed that Board Meeting of the Company was held on Monday, November 11, 2019 at the registered office of the Company. The Board has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2019. A copy of unaudited financial results along with the Limited Review Report of the Auditor of the Company are enclosed herewith as Annexure-I. The meeting of the Board of Directors commenced at 6.30 pm and concluded at 9.15 pm.
The above information is a part of company’s filings submitted to BSE.
